A meta‐analysis of toxicities related to hydroxycarbamide dosing strategies

Joacy G. Mathias(University of North Carolina at Chapel Hill), Jeremie H. Estepp(St. Jude Children's Research Hospital), Jane S. Hankins(St. Jude Children's Research Hospital), Kristen E. Howell(Texas A&M University), Winfred C. Wang, Val Nolan(University of Memphis), Meghan M. Taylor(University of Memphis), James G. Gurney(University of Michigan)
eJHaem
April 26, 2020
10.1002/jha2.7
Cited by 3

Related Papers

Clinical Ascertainment of Health Outcomes Among Adults Treated for Childhood Cancer
|JAMA|2013|1.3k
Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study
|Blood|2007|536
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: A report from the childhood cancer survivor study
|Pediatric Blood & Cancer|2013|459
Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings
|Journal of Clinical Oncology|2009|418
Medical Care in Long-Term Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study
|Journal of Clinical Oncology|2008|418